Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN24648386
ISRCTN24648386
Completed
未知

Effects of growth hormone treatment after final height in Prader-Willi Syndrome: a double-blind multicentre, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transition

Dutch Growth Foundation (Netherlands)0 sites20 target enrollmentSeptember 5, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrader Willi SyndromeNutritional, Metabolic, EndocrineDisorders of other endocrine glands

Overview

Phase
未知
Intervention
Not specified
Conditions
Prader Willi Syndrome
Sponsor
Dutch Growth Foundation (Netherlands)
Enrollment
20
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 5, 2007
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dutch Growth Foundation (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Young adults, originally participating in the Dutch GH study in PWS children (ISRCTN49726762\) or otherwise GH\-treated patients
  • •2\. Final height is reached or epiphysial fusion is complete
  • •3\. Treated with GH during childhood for at least two years

Exclusion Criteria

  • •1\. Non\-cooperative behaviour
  • •2\. Extremely low dietary intake of less than minimal required intake according to World Health Organisation (WHO)
  • •3\. Medication to reduce weight (fat)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transition - Effects of GH after final height in PWSPrader-Willi SyndromeMedDRA version: 9.1Level: LLTClassification code 10036476Term: Prader-Willi syndrome
EUCTR2007-004716-31-NLDutch Growth Foundation
Completed
Not Applicable
Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transitioPrader-Willi Syndrome10029299
NL-OMON39086Erasmus MC, Universitair Medisch Centrum Rotterdam26
Not yet recruiting
Not Applicable
Effects of growth hormone treatment after final height in Prader-Willi SyndromePrader-Willi SyndromePrader-Willi Syndroom
NL-OMON28633Dutch Growth Foundation20
Active, not recruiting
Not Applicable
Effects of growth hormone treatment to patients with partial growth hormone deficiency, with special emphasis on acute phase proteins and pro-inflammatory cytokines.
EUCTR2005-004478-26-SEKarolinska universitetssjukhuset
Not yet recruiting
Phase 3
Investigating the results of adding growth hormone to the ovulation stimulation regimen in microinjection and In Vitro Fertilization in patients with low ovarian reserve
IRCT20130603013566N13Vice chancellor for Research,Tabriz University Of Medical Sciences96